Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II chemoradiotherapy with 5-FU + cisplatin followed by S-1 in stage IA esophageal cancer
jRCTs051180094Phase 2Recruiting
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in esophageal cancer. Primary endpoint: Progression-free survival. Started Dec 2014; status: recruiting.
02
Drugs
tegafur
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCTs051180094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180094.